Recent Accomplishments and Honors
1995 The Litz Award: given by the faculty for outstanding performance in internal medicine, University of Virginia
1990 Phi Sigma Biological Honor Society, Bucknell University

Training
1998-2001 University of North Carolina, Chapel Hill, NC:
Fellowship in Hematology/Oncology
1995-1998 University of Michigan, Ann Arbor, MI:
Residency in internal medicine
1991-1995 University of Virginia, Charlottesville, VA:
MD in May 1995
1987-1991 Bucknell University, Lewisburg PA:
BS in Biology, June 1991

Publications
Paul A. Godley and Thomas Stinchcombe. Renal Cell Carcinoma. Current Opinion in Oncology 1999 May, 11 (3): 213-7

Thomas E. Stinchcombe and Mark A. Socinski. General Aspects of Chemotherapy in Detterbeck, FC; Rosenman, J; Socinski, MA; Rivera, MP. (Eds) Diagnosis and Treatment of Lung Cancer W.B. Saunders, Philadelphia, PA 2000

H.R. Roberts, Thomas E. Stinchcombe, D. Gabriel. The Dysfibrinogenemias. The British Journal of Hematology 2001 August, 114 (2) 249-52.

R.Z. Orlowski, Thomas E. Stinchcombe, B.S. Mitchell, et al. Phase I Trial of the Proteasome Inhibitor PS-341 in patients with Refractory Hematologic Malignancies Journal of Clinical Oncology 2002 November 15 20 (22): 4420-4427

Thomas E. Stinchcombe and Stephen A. Bernard. Palliative Care in Advanced Cancer In Netters Internal Medicine ICON Learning Systems June 2003

L. Fischer, C. Mahoney, A.R. Jeffcoat, M.A. Koch, B.F. Thomas, J. Valentine, Thomas E. Stinchcombe, J. Knowles, J.A. Crowell, S. Zeisel. Clinical characteristics and Pharmacokinetics of Purified Soy Isoflavones: Multiple Dose Administration to Men with Prostate Neoplasia. Nutrition and Cancer . Nutrition and Cancer 2004 March 48 (2): 160-170

Heidi H. Gillenwater, Thomas E. Stinchcombe, Bahjat F. Qaqish, Maureen Tynan
Thomas Hensing and Mark Socinski A Phase II Trial of Weekly Paclitaxel and
Gemcitabine Infused at a Constant rate in Patients with Advanced Non-Small Cell
Lung Cancer Lung Cancer 2005. 47:413-419

Thomas E. Stinchcombe and Mark A. Socinski. Drug Development in Patients with
Advanced Non-Small Cell Lung Cancer and Poor Performance Status. Seminars
in Oncology 2004 31 (suppl 11):21-26

Mark A. Socinski, Thomas E. Stinchcombe, and D. Neil Hayes. The Evolving Role of Pemetrexed (Alimta) in Lung Cancer. Seminars in Oncology 2005. 32(suppl 2):S16-22

Thomas E. Stinchcombe, Jaeun Choi, Michael J. Schell, Andrea Mears, Paul E. Jones, Robert V. Nachtsheim and Mark A. Socinski. Carboplatin-based Chemotherapy in Patients with Advanced Non-Small Cell lung Cancer and a Poor Performance Status. Lung Cancer 2006. 51, 237-43

Thomas E. Stinchcombe and Mark A. Socinski. Integration of Biological Therapies in Locally Advanced Non-Small Cell Lung Cancer. In Tumors of the Chest: Biology, Diagnosis, and Management

Thomas E. Stinchcombe, D. Neil Hayes and Mark A. Socinski. Commentary on Perspectives on Salvage Therapy for Non-small cell Lung Cancer Oncology 2005 19 (8) 1003-06

Mark A. Socinski, Thomas E. Stinchcombe, D.Neil Hayes, and David E. Morris. The Emergence of a Unique Population in Non-Small Cell Lung Cancer: Systemic and Loco-regional relapse following Post-operative adjuvant Platinum-based chemotherapy. Seminars in Oncology 2005.33 (suppl 1): 32-38

Thomas E. Stinchcombe, David E. Morris, Dominic T. Moore, John Bechtel, Jan S. Halle, Andrea Mears, Katherine Deschesne, Julian Rosenman and Mark A. Socinski. Post Chemotherapy Gross Tumor Volume is predictive of survival in Patients with Stage III Non-Small Cell Lung Cancer treated with Combined Modality Therapy. Lung Cancer 2006. 52, 67-74

Thomas E. Stinchcombe, Petra Bůkov, Janak Choksi, Mark Taylor, Kamal Bakri, Heidi Gillenwater, Maureen Tynan, Andrea Mears, Paul E. Jones and Mark A. Socinski. A Phase I/II Trial of Weekly Docetaxel and Gefitinib in Elderly Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Journal of Thoracic Oncology 2006. 52 (3) 305-11

Thomas E. Stinchcombe, Carrie Lee, and Mark A. Socinski. Current Approaches to Patients with Advanced Non-Small Cell Lung Cancer Clinical Lung Cancer 2006, 7 suppl S111-17

Thomas E. Stinchcombe, Daniel Fried David E. Morris Mark A. Socinski. Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer. The Oncologist 2006; 11 (7); 809-23

Thomas E. Stinchcombe, Lisa M. Gangarosa, Amir H. Khandani, Mark A. Socinski. Squamous Cell Cancer of the Lung presenting with a Solitary Metastatic Lesion to the Colon from detected on Positron Emission Tomography Scan Journal of Clinical Oncology 2006; 24 (30) 4939-40

Thomas E. Stinchcombe, Mark A. Socinski, Christine M. Walko, Bert Oneil, Frances A. Collichio, Anastasia Ivanova, Hua Mu, Michael J. Hawkins, Richard M/ Goldberg, Celeste Lindley, and E. Claire Dees. Phase I and Pharmacokinetic Trial of the Combination of Carboplatin and Albumin-bound Paclitaxel, ABI-007, on Three Treatment Schedules 2007, Feb 7(Epub ahead of print)

Thomas E. Stinchcombe and Mark A. Socinski. Role of Chemotherapy in Early Stage Non-Small Cell Lung Cancer: Evidence to Date. Drugs 2007; 67 (3): 321-32

Carrie B. Lee, Thomas E. Stinchcombe, Julian G. Rosenman. Therapeutic Advances in Local Regional Therapy for Stage III Non-Small Cell Lung Cancer: The Evolving Role of Dose Escalated Conformal (3-Dimensional) Radiotherapy Clinical Lung Cancer 2006; 8 (3): 195-202

Thomas E. Stinchcombe. Thyroid Cancer. In Netters Internal Medicine, second edition (in press)

Thomas E. Stinchcombe and Mark A. Socinski. Bevacizumab in the Treatment of Non-Small Cell Lung Cancer. (in press in Oncogene)

Stephen A. Bernard and Thomas E. Stinchcombe. Palliative Care for Patients with Advanced Cancer. In Netters Internal Medicine second edition (in press)

Thomas E. Stinchcombe, Ruth Walters, Amir H. Khandani, and Mark A.Socinksi. Radiation-induced sarcoma after Treatment with High Dose (74 Gy) Thoracic Radiation Therapy for Stage III Non-Small Cell Lung Cancer (in press Journal of Clinical Oncology)

Thomas E. Stinchcombe and Mark A. Socinski. Considerations for Second-line Therapies (submitted to the Oncologist)

Maria Q. Baggstrom*, Thomas E. Stinchcombe*, Daniel B. Fried, Charles Poole, Thomas A. Hensing, Mark A. Socinski. Third Generation Chemotherapy Agents in the Treatment of advanced non-small cell lung cancer: A Meta-analysis. (submitted to the Journal of Thoracic Oncology)
* Maria Q. Baggstrom and Thomas E. Stinchcombe contributed equally to this article

E-mail: thomas_stinchcombe@med.unc.edu
Telephone: (919) 966-9268
FAX: (919) 966-6735
Address: 3009 Old Clinic Bldg Chapel Hill, NC 27599

Click here to update this profile